logo

SGHT

Sight Sciences·NASDAQ
--
--(--)
--
--(--)
1.72 / 10
Underperform

SGHT's fundamental assessment is weak (1.7/10), marked as Underperform. Key concerns include negative asset-to-market and revenue-to-market value ratios, low cash-to-market, and poor profitability metrics such as ROA and net profit margin. Only the interest-coverage ratio and net profit/total profit ratio are favorable. Historical back-tests for most factors show negative one-month returns, reinforcing the weak quality score and indicating that the stock may underperform on a stand-alone basis without external catalysts.

Fundamental(1.72)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.47
Score0/3
Weight17.13%
1M Return-3.84%
ROA (%)
Value-26.45
Score2/3
Weight1.81%
1M Return-0.39%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight7.85%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight11.08%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight19.13%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-35.27
Score2/3
Weight1.81%
1M Return-0.39%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.85%
1M Return-1.95%
Asset-MV
Value-0.50
Score1/3
Weight3.09%
1M Return-0.63%
Cash-MV
Value-0.07
Score1/3
Weight21.02%
1M Return-5.64%
Net profit / Total profit (%)
Value100.01
Score2/3
Weight8.24%
1M Return-1.71%
Is SGHT undervalued or overvalued?
  • SGHT scores 1.72/10 on fundamentals and holds a Premium valuation at present. Backed by its -45.14% ROE, -60.63% net margin, -6.73 P/E ratio, 4.83 P/B ratio, and 10.89% earnings growth, these metrics solidify its Underperform investment rating.